Alex Beatson co-founded Axiom Bio, where he builds AI systems to predict and reduce drug toxicity. He previously led molecular machine-learning work at Redesign Science and Genesis Therapeutics after completing a Princeton PhD in deep learning and generative modeling.
Alex Beatson co-founded Axiom Bio, where he builds AI systems to predict and reduce drug toxicity. He previously led molecular machine-learning work at Redesign Science and Genesis Therapeutics after completing a Princeton PhD in deep learning and generative modeling.
Career
Co-founder at Axiom Bio from 2024-01 to PresentRSDirector of Machine Learning at Redesign Science from 2022-01 to 2023-01
Principal Research Scientist at Genesis Therapeutics from 2021-01 to 2022-01
Google Brain Intern at Google from 2017-01 to 2017-12